Cargando…

Regulatory Effects of Histone Deacetylase Inhibitors on Myeloid-Derived Suppressor Cells

Histone deacetylase inhibitors (HDACIs) are antitumor drugs that are being developed for use in clinical settings. HDACIs enhance histone or nonhistone acetylation and promote gene transcription via epigenetic regulation. Importantly, these drugs have cytotoxic or cytostatic properties and can direc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Yudan, Cai, Jingshan, Wang, Wenxin, Wang, Shengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208029/ https://www.ncbi.nlm.nih.gov/pubmed/34149732 http://dx.doi.org/10.3389/fimmu.2021.690207

Ejemplares similares

Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy
por: Adeshakin, Adeleye O., et al.
Publicado: (2022)

Function of reactive oxygen species in myeloid-derived suppressor cells
por: Huang, Jiaojiao, et al.
Publicado: (2023)

Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis
por: Li, Min, et al.
Publicado: (2018)

TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host
por: Song, Ge, et al.
Publicado: (2021)

A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy
por: Chen, Zude, et al.
Publicado: (2023)

Dietary Inhibitors of Histone Deacetylases in Intestinal Immunity and Homeostasis
por: Schilderink, R., et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

Erratum: Dietary Inhibitors of Histone Deacetylases in Intestinal Immunity and Homeostasis
por: Schilderink, R., et al.
Publicado: (2013)

Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma
por: Siret, Carole, et al.
Publicado: (2020)

Checkpoint Blockade Rescues the Repressive Effect of Histone Deacetylases Inhibitors on γδ T Cell Function
por: Bhat, Sajad A., et al.
Publicado: (2018)

The Yin and Yang of Myeloid Derived Suppressor Cells
por: Budhwar, Snehil, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells in Lung Transplantation
por: Heigl, Tobias, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells in Colorectal Cancer
por: Sieminska, Izabela, et al.
Publicado: (2020)

Myeloid-derived suppressor cells and pulmonary hypertension
por: Zhang, Hui, et al.
Publicado: (2023)

Effect of Angelica polysaccharide on mouse myeloid-derived suppressor cells
por: Shen, Jie, et al.
Publicado: (2022)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Epigenetic Regulation of Host Defense Peptide Synthesis: Synergy Between Histone Deacetylase Inhibitors and DNA/Histone Methyltransferase Inhibitors
por: Whitmore, Melanie A., et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
por: Weber, Rebekka, et al.
Publicado: (2018)

Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1–HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer
por: Tian, Xinyu, et al.
Publicado: (2018)

Myeloid-derived suppressor cell: A crucial player in autoimmune diseases
por: Xu, Dandan, et al.
Publicado: (2022)

Corrigendum: Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1–HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer
por: Tian, Xinyu, et al.
Publicado: (2020)

The emerging role of histone deacetylase 1 in allergic diseases
por: Wang, Yongfang, et al.
Publicado: (2022)

Granulocytic Myeloid-Derived Suppressor Cell Exosomal Prostaglandin E2 Ameliorates Collagen-Induced Arthritis by Enhancing IL-10(+) B Cells
por: Wu, Xinyu, et al.
Publicado: (2020)

The Role of Myeloid-Derived Suppressor Cells in Immune Ontogeny
por: Gantt, Soren, et al.
Publicado: (2014)

Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections
por: Dorhoi, Anca, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
por: Consonni, Francesca Maria, et al.
Publicado: (2019)

The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
por: Magcwebeba, Tandeka, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
por: Pawelec, Graham, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells in Pregnancy and the Neonatal Period
por: Köstlin-Gille, Natascha, et al.
Publicado: (2020)

Editorial: Myeloid Derived Suppressor Cells as Disease Modulators
por: Finn, Olivera J., et al.
Publicado: (2020)

Granulocytic Myeloid-Derived Suppressor Cells in Cystic Fibrosis
por: Tucker, Samantha L., et al.
Publicado: (2021)

The role of myeloid derived suppressor cells in musculoskeletal disorders
por: Ren, Yi, et al.
Publicado: (2023)

Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
por: Leukes, Vinzeigh, et al.
Publicado: (2020)

Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors
por: Ungerstedt, Johanna S.
Publicado: (2018)

Intracellular Lipid Accumulation Drives the Differentiation of Decidual Polymorphonuclear Myeloid-Derived Suppressor Cells via Arachidonic Acid Metabolism
por: Wang, Qiaohong, et al.
Publicado: (2022)

Exosomes released by granulocytic myeloid-derived suppressor cells attenuate DSS-induced colitis in mice
por: Wang, Yungang, et al.
Publicado: (2016)

Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis
por: He, Ying, et al.
Publicado: (2021)

Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors
por: Xu, Qing-Yu, et al.
Publicado: (2020)

Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis
por: Nijhuis, Lotte, et al.
Publicado: (2019)

Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors
por: Hou, Aohan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_83uhrt2gjgp0godgbbrjmi914h